Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 金陵药业股份有限公司是科工贸一体化、产学研相结合的大型药品现代化上市公司.公司主要产品和品种有:脉络宁系列产品、塞莱乐、双香排石颗粒、速力菲、胃得安、香菇多糖、丝白袪斑软膏、筋络宁、慢咽宁、明胶海绵等一百六十多个产品与品种,其中"脉络宁注射液"、"胃得安片"、"香菇多糖注射液"为国家中药保护品种.2008 年10月,公司被认定为江苏省2008年度高新技术企业.2010年,公司与中国药科大学成立了"新型药物制剂"联合实验室。
Main Business 中药原料和制剂、西药制剂的生产和销售，以及医药新产品研制、技术服务和开发。
Legal Representative 陈胜
Top Executives
董事长：陈胜
董事：王健,汪洋,陈海,张群洪,曹小强,陈胜,汤卫国
独立董事：高燕萍,沈永建,寇俊萍
Top 5 Shareholder
Shareholder name Nature Holding Date
南京新工投资集团有限责任公司限售股+流通A股41.23%22/04/2024
福州市投资管理有限公司流通A股3.66%22/04/2024
南京科诚软件技术有限公司限售股+流通A股2.50%22/04/2024
江苏高科技投资集团有限公司-江苏国有企业混合所有制改革基金（有限合伙）限售股2.50%22/04/2024
合肥市工业投资控股有限公司流通A股1.54%22/04/2024
Company Secretary 汪洋
Solicitors 江苏泰和律师事务所
Auditors 天衡会计师事务所（特殊普通合伙）
Tel No 025-83118511
Fax No 025-83112486
Website www.jlyy1999.com
Email jlyyemail@163.com
Company Address
Register: 江苏省南京市经济技术开发区新港大道58号
Office: 江苏省南京市中央路238号金陵药业大厦
Listing Date 18/11/1999
Shares Capital
Shares Capital: 629,060,528
Total A Share: 629,060,528
Listed A Share: 503,263,097
Non-tradable A Share: 125,797,431
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.198
DPS(RMB)* ¥ 0.100
NBV Per Share(RMB)* ¥ 5.953
Market Capitalization(RMB) 3.503B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.